Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
147.09
-3.82 (-2.53%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Sep 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Healthcare Stocks with Warning Signs
Today 0:33 EDT
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via
StockStory
Tuesday's session: top gainers and losers in the dow jones index
↗
September 22, 2026
Via
Chartmill
Uncover the latest developments among dow jones stocks in today's session.
↗
September 22, 2026
Via
Chartmill
Meta's Muse Sends the Nasdaq to a Record and Rekindles the AI Trade
↗
September 22, 2026
Via
Chartmill
Topics
Artificial Intelligence
BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline?
↗
September 22, 2026
Investors buying this biotech stock now will get its pipeline essentially for free.
Via
The Motley Fool
3 Reasons to Sell MRK and 1 Stock to Buy Instead
September 22, 2026
Over the past six months, Merck has been a great trade, beating the S&P 500 by 13.4%. Its stock price has climbed to $149.98, representing a healthy 29.6% in...
Via
StockStory
Topics
Stocks
These dow jones stocks are moving in today's session
↗
September 21, 2026
Via
Chartmill
Discover which dow jones stocks are making waves on Monday.
↗
September 21, 2026
Via
Chartmill
BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried?
↗
September 18, 2026
BioNTech's recent pipeline setback is a real cause of concern. But investors shouldn't panic.
Via
The Motley Fool
Discover which dow jones stocks are making waves on Thursday.
↗
September 17, 2026
Via
Chartmill
These dow jones stocks are moving in today's session
↗
September 17, 2026
Via
Chartmill
JEPI and JEPQ Yield Way More Than SCHD, but SCHD Could Produce More Passive Income Over the Long Term. Here's Why.
↗
September 17, 2026
Long-term holders of the Schwab U.S. Dividend Equity ETF have seen their yield on cost gradually rise.
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
Uncover the latest developments among dow jones stocks in today's session.
↗
September 16, 2026
Via
Chartmill
Discover which dow jones stocks are making waves on Tuesday.
↗
September 15, 2026
Via
Chartmill
Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive Transformation
↗
September 14, 2026
Merck & Co., Inc. (NYSE:MRK) Chairman and CEO Rob Davis said the company’s “transformation is underway,” citing progress across product launches, clinical data readouts, business development and its...
Via
MarketBeat
Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger?
↗
September 14, 2026
The biotech is entering a new era.
Via
The Motley Fool
Blue-Chip Stocks Are Looking Anything But Boring With Dividends and Big 2026 Gains
↗
September 14, 2026
Coca-Cola, Chevron, and Merck have outperformed the S&P 500 in 2026, each pairing strong share-price gains with growing dividends backed by solid fundamentals.
Via
MarketBeat
Topics
Artificial Intelligence
Intellectual Property
Stocks
2 Outstanding Dividend Stocks to Buy and Hold for 10 Years
↗
September 12, 2026
Income seekers can't go wrong with these companies.
Via
The Motley Fool
Topics
Intellectual Property
Friday's session: top gainers and losers in the dow jones index
↗
September 11, 2026
Via
Chartmill
These dow jones stocks are moving in today's session
↗
September 11, 2026
Via
Chartmill
These 5 ETFs Are Built for Bear Markets. History Says Now Is a Fantastic Time to Buy.
↗
September 10, 2026
During bear markets and recessions, it's good to be invested in "defensive" stocks and funds that hold up better than average.
Via
The Motley Fool
Topics
ETFs
Economy
Which dow jones stocks are moving on Thursday?
↗
September 10, 2026
Via
Chartmill
Explore the top gainers and losers within the dow jones index in today's session.
↗
September 10, 2026
Via
Chartmill
Recent Filing Shows That Rep. Maria Elvira Salazar Bought Over $34K Worth of Merck & Co Stock
↗
September 10, 2026
September 9, 2026 records indicate that Representative Maria Elvira Salazar filed a purchase of Merck & Co (NYSE:MRK), valued between $34,006 and $160,000. According to the September filing, the...
Via
Benzinga
Merck Targets $70B Pipeline as It Prepares for KEYTRUDA Exclusivity Loss
↗
September 10, 2026
Merck & Co., Inc. (NYSE:MRK) executives outlined a strategy centered on pipeline investment, new product launches and targeted business development as the company prepares for the eventual loss of...
Via
MarketBeat
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
↗
September 06, 2026
Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes.
Via
MarketBeat
Topics
Artificial Intelligence
Bonds
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
↗
September 04, 2026
The vaccine maker is making an increasingly robust case that it isn't just a pandemic stock.
Via
The Motley Fool
Revolution Medicines Got Its Breakthrough—What Moves It Next?
↗
September 04, 2026
FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus.
Via
MarketBeat
Which dow jones stocks are moving on Friday?
↗
September 04, 2026
Via
Chartmill
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
↗
September 03, 2026
Both have attracted considerable attention from Wall Street recently.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today